Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4664-01-1 | MDL No. : | MFCD00013439 |
Formula : | C7H4N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SJSABZBUTDSWMJ-UHFFFAOYSA-N |
M.W : | 148.12 | Pubchem ID : | 72926 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 39.61 |
TPSA : | 59.06 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.45 cm/s |
Log Po/w (iLOGP) : | 0.59 |
Log Po/w (XLOGP3) : | -0.35 |
Log Po/w (WLOGP) : | -0.42 |
Log Po/w (MLOGP) : | 0.06 |
Log Po/w (SILICOS-IT) : | 1.05 |
Consensus Log Po/w : | 0.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.94 |
Solubility : | 16.9 mg/ml ; 0.114 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.43 |
Solubility : | 55.3 mg/ml ; 0.373 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.38 |
Solubility : | 0.61 mg/ml ; 0.00412 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.37 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
17% | Stage #1: for 24 h; Reflux Stage #2: With calcium chloride In dichloromethane |
To a solution of 3,4-pyridindicarboxamide (0.40 g, 2.7 mmol, 1 eq) in acetic acid (12 mL), zinc (0.78 g, 11.9 mmol, 4.4 eq) was added and the suspension was heated at reflux for 24 h. After cooling at room temperature, the mixture was filtered off through a Celite pad. The filtrate was evaporated and the residue was taken up with CH2Cl2. To this solution CaCl2 was added and the suspension was filtered. The filtrate was evaporated and the residue was purified by column chromatography using EtOAc/MeOH 95/5 as eluant to give 10 as yellowish solid after crystallization with EtOH (0.061 g, 17percent). Mp. 190-193 °C dec. 1H NMR (300 MHz, DMSO-d6) δ 8.84 (s, 1-H), 8.70 (br d, 2-H), 7.62 (d, J = 5.5 Hz, 1-H), 4.42 (s, 2-H); 13C NMR (75 MHz, DMSO-d6) δ 169.1, 153.3, 151.6, 145.3, 129.0, 119.9, 45.2; GC-MS m/z 134 (M)+; IR (KBr) 2856, 1728, 1692, 1455, 1206, 1026 cm-1. Anal. Calcd for C7H6N2O: C, 62.68; H, 4.51; N, 20.88. Found: C, 62.75; H, 4.50; N, 20.63. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95.1% | Stage #1: at 140 - 150℃; Stage #2: at 140℃; for 3 h; |
A suspension of cinchomeronic acid (30)(50 g, 300 mmol) in acetic anhydride (123.5 g, 1200 mmol) was heated to reflux (140-150° C.) until all solid material dissolved and the mixture was homogeneous. The mixture was then cooled and concentrated in vacuo. Acetamide (50 g, 846 mmol) was then added and the mixture heated to 140° C. for 3 hours whereupon it was then cooled to room temperature. The solid residue that formed upon cooling was pulverized and triturated with water (100 ml), filtered and washed with more water and dried in a desiccator to give the title compound (42.26 g, 95.1percent) in suitably pure form to be used without any further purification. m/z (LC-MS, ESP): 149 [M+H]+, R/T=0.44 mins. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With bromine; sodium hydroxide In water at 90℃; for 0.666667 h; Cooling with ice | Step 1 To 10percent aqueous sodium hydroxide solution (100 mL) was added bromine (1.93 mL, 38.6 mmol) under ice-cooling, and 1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione (5.20 g, 35.1 mmol) was subsequently added. 10percent-Aqueous sodium hydroxide solution (60 mL) was added to the reaction mixture, and the mixture was stirred with heating at 90° C. for 40 min. After allowing to cool to room temperature, 50percent sulfuric acid was added to adjust the reaction mixture to pH 3. The precipitated insoluble material was collected by filtration, and the solid was washed with water to give 3-aminoisonicotinic acid as a pale-yellow powder (5.00 g, 100percent). 1H-NMR (200 MHz, DMSO-d6) δ: 7.46 (1H, d, J=5.1 Hz), 7.73 (1H, d, J=5.1 Hz), 8.21 (1H, s). |
68.33% | Stage #1: With sodium hydroxide; bromine In water at 7 - 80℃; for 0.5 h; Stage #2: With acetic acid In water at 37℃; |
NaOH (10percent aqueous, 640 ml) was cooled to 7° C. and bromine (15 ml, 286.82 mmol) added dropwise. Pyrrolo[3,4-c]pyridine-1,3-dione (41.711 g, 281.6 mmol) was then added to the reaction mixture before it was heated to 80° C. for 30 minutes. After this time the reaction was allowed to warm to 37° C. and the pH modified to 5.5 by the addition of acetic acid (70 ml). A suspension formed that was removed by filtration and washed with 20 ml of ice cold methanol to give the title compound (26.58 g, 68.33percent) in a suitably clean form to be used without any further purification. m/z (LC-MS, ESP): 139 [M+H]+, R/T=0.72 mins. |
67% | Stage #1: With sodium hydroxide; bromine In water at 0 - 80℃; for 0.75 h; Stage #2: With acetic acid In water |
Bromine (3. 5 ml, 69.0 mmol) was added to a solution of 10 percent aqueous sodium hydroxide (120 ml) at 0 C to give a pale yellow solution. To this solution was added 3,4-pyridinedicarboximide (10 g, 67. 5 mmol) and the reaction was heated at 80 C for 45 min. The reaction was cooled in a water bath and acidified by the addition of acetic acid (12. 5 ml) causing precipitation. The solid was collected, rinsed with water(50 ml), thenMeOH(50 ml) and dried to give the title compound as a beige solid (6.28 g, 67 percent).1H NMR (360 MHz, DMSO)5 8. 06 (1H, s), 7.60(1H, d,J5. 1), 7.34(1H, d,J5. 1), 3.19 (2H, brs). M/z (ES+) 139 (M+H+). |
64% | Stage #1: With sodium hydroxide; bromine In water at 80℃; for 1.1667 h; Stage #2: With acetic acid In water at 20℃; for 0.166667 h; |
Following the procedures of Zhou et al (2001) Bioorg. Med. Chem. Lett.9(8):2061-2071, bromine (1.22 ml, 23.9 mmol) was slowly added to a cooled (50C) 2.5N solution of NaOH (60 ml, 150 mmol) and after stirring for 5 minutes pyrrolo[3,4-c]pyridine- 1,3-dione (3.5 g, 23.6 mmol) was added. The temperature was raised to 8O0C and the mixture was stirred for 1 hour before being cooled to ambient temperature. Acetic acid (5.9 ml, 98.3 mmol) was cautiously added (N.B.: gas evolution) and the solution stirred for 10 minutes whereby a precipitate formed that was collected by filtration. The solid was washed with water (20 ml) and MeOH (20 ml) then dried to afford the title compound as a yellow solid (2.1 g, 64percent). |
62% | With sodium hydroxide; bromine In water at 0 - 80℃; for 0.75 h; | A solution of10percent aqueousNaOH (416 mL) was cooled to0 C and treated with bromine (28.2 g 176 mmol) portionwise via pipette while keeping the temperature below 5 C. To this mixture was added 3,4-pyridinedicarboximide (25.78 g, 174mmol), and the cooling bath was removed. The reaction was heated to80 C for 45 min, then allowed to cool in an ice bath. When the temperature fell to 60 C, the dropwise addition of HOAc (50 mL) was started. Cooling was continued until the temperature reached 15 C. A yellow precipitate formed. The solid was filtered, rinsed with water, then dried under vacuum to give 14.9 g of product (108 mmol,62percent). 1NMR IS-MS, m/e 139(m+1) |
57% | With bromine In sodium hydroxide | Preparation 18 3-Aminopyridine-4-carboxylic acid To an ice cold mixture of 3,4-pyridinedicarboximide (5.2 g, 35.11 mmol) in 10percent sodium hydroxide (85 mL) was added bromine (1.84 mL, 35.8 mmol), dropwise. The resulting solution was heated to 80° C. for 1 hour, cooled on ice, and the acidity was carefully adjusted to pH 5.5 with acetic acid. The precipitate was collected, washed well with water and air dried to afford 3-aminopyridine-4-carboxylic acid (2.74 g, 57percent). NMR (DMSO d6) δ8.20 (s, 1H), 7.72 (d, J=5 Hz, 1H), 7.45 (d, J=5 Hz, 1H). The material was used without purification. |
57% | Stage #1: With sodium hydroxide; bromine In water at 7 - 85℃; for 1.5 h; Stage #2: With acetic acid In water at 20 - 30℃; |
Step A: 3-Aminoisonicotinic acid: 2H-Pyrrolo[3,4-c]pyridine-1,3-dione (204.16 g, 1378.4 mmol) was dissolved in 10percent NaOH (3.3 L) and the solution was cooled to an internal temperature of 7° C. (ice/salt bath). Bromine (73.424 mL, 1433.5 mmol) was added dropwise while maintaining the internal temperature below 10° C. After completion of the addition, the reaction was heated to an internal temperature of 80-85° C. for 90 minutes. The reaction mixture was cooled to 20-30° C. in an ice bath then acetic acid (323.21 mL, 5651.2 mmol) was added dropwise. The reaction was stirred and cooled to 5° C. The solids were collected by vacuum filtration, washed with cold water then air-dried to provide the product (108.86 g, 57percent). |
57% | With bromine In sodium hydroxide | Preparation 18 3-Aminopyridine-4-carboxylic acid To an ice cold mixture of 3,4-pyridinedicarboximide (5.2 g, 35.11 mmol) in 10percent sodium hydroxide (85 mL) was added bromine (1.84 mL, 35.8 mmol), dropwise. The resulting solution was heated to 80° C. for 1 hour, cooled on ice, and the acidity was carefully adjusted to pH 5.5 with acetic acid. The precipitate was collected, washed well with water and air dried to afford 3-aminopyridine-4-carboxylic acid (2.74 g, 57percent). 1H NMR (DMSO d6) δ8.20 (s,1 H), 7.72 (d, J=5 Hz, 1 H), 7.45 (d, J=5 Hz, 1 H). The material was used without purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57% | With bromine In sodium hydroxide | Preparation 18 3-Aminopyridine-4-carboxvlic acid To an ice cold mixture of 3,4-pyridinedicarboximide (5.2 g, 35.11 mmol) in 10percent sodium hydroxide (85 mL) was added bromine (1.84 mL, 35.8 mmol), dropwise. The resulting solution was heated to 80°C for 1 hour, cooled on ice, and the acidity was carefully adjusted to pH 5.5 with acetic acid. The precipitate was collected, washed well with water and air dried to afford 3-aminopyridine4-carboxylic acid (2.74 g, 57percent). NMR (DMSO d6) δ 8.20 (s, 1 H), 7.72 (d, J = 5 Hz, 1 H), 7.45 (d, J = 5 Hz, 1 H). The material was used without purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | Stage #1: at 100℃; for 4 h; |
Step lTo a solution of compound [137] (3 g, 20.2 mmol, leq) in glacial acetic acid (30 ml), Zn dust (5.26 g, 81.0 mmol, 4 eq.) was added and the reaction mixture was refluxed at 100 °C for 4 h. The reaction mixture was cooled to room temperature and the solvent was evaporated. The reaction mass was made basic with aqueous NaHC03 to pH 8 and extracted with chloroform. The aqueous layer was concentrated and further extracted with chloroform. The combined organic layer was dried over Na2S04 and evaporated to give [138] as a peach white solid (1.7 g, 62percent).ESIMS: 135 (M+ + 1) |
[ 40107-95-7 ]
1H-Pyrrolo[3,4-c]pyridin-3(2H)-one
Similarity: 0.97
[ 62936-56-5 ]
Sodium 4-(nicotinamido)butanoate
Similarity: 0.76
[ 40107-95-7 ]
1H-Pyrrolo[3,4-c]pyridin-3(2H)-one
Similarity: 0.97
[ 40107-93-5 ]
6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one
Similarity: 0.73
[ 155058-02-9 ]
7,8-Dihydro-1,6-naphthyridin-5(6H)-one
Similarity: 0.72
[ 6000-50-6 ]
2,3-Dihydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride
Similarity: 0.71
[ 16952-65-1 ]
Pyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione
Similarity: 0.71